Pelong, Diosdado B.
HRN: 07-15-14 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/27/2023
03/27/2023
IV
4.5 Grams
Once
CAP-MR
Waiting Final Action
Indication: EmpiricEmpirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes